Abstract
Experience in the use of 5-azacytidine, bortezomib and valproic acid for the prevention of leukemia relapses in children after ab-T cell-depleted hematopoietic stem cell transplantation
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have